chr20-3671968-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000356518.7(ADAM33):c.1615G>A(p.Glu539Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000983 in 1,555,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000087 ( 0 hom. )
Consequence
ADAM33
ENST00000356518.7 missense
ENST00000356518.7 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.74
Genes affected
ADAM33 (HGNC:15478): (ADAM metallopeptidase domain 33) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This protein is a type I transmembrane protein implicated in asthma and bronchial hyperresponsiveness. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.057273358).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM33 | NM_025220.5 | c.1615G>A | p.Glu539Lys | missense_variant | 15/22 | ENST00000356518.7 | NP_079496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM33 | ENST00000356518.7 | c.1615G>A | p.Glu539Lys | missense_variant | 15/22 | 1 | NM_025220.5 | ENSP00000348912 | P4 | |
ADAM33 | ENST00000379861.8 | c.1615G>A | p.Glu539Lys | missense_variant | 15/22 | 1 | ENSP00000369190 | A2 | ||
ADAM33 | ENST00000466620.5 | n.1254G>A | non_coding_transcript_exon_variant | 5/11 | 1 | |||||
ADAM33 | ENST00000350009.6 | c.1615G>A | p.Glu539Lys | missense_variant | 15/21 | 5 | ENSP00000322550 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152226Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
30
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000929 AC: 15AN: 161436Hom.: 0 AF XY: 0.0000469 AC XY: 4AN XY: 85338
GnomAD3 exomes
AF:
AC:
15
AN:
161436
Hom.:
AF XY:
AC XY:
4
AN XY:
85338
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000869 AC: 122AN: 1403368Hom.: 0 Cov.: 35 AF XY: 0.0000823 AC XY: 57AN XY: 692620
GnomAD4 exome
AF:
AC:
122
AN:
1403368
Hom.:
Cov.:
35
AF XY:
AC XY:
57
AN XY:
692620
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000203 AC: 31AN: 152344Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74504
GnomAD4 genome
AF:
AC:
31
AN:
152344
Hom.:
Cov.:
33
AF XY:
AC XY:
15
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
7
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1615G>A (p.E539K) alteration is located in exon 15 (coding exon 15) of the ADAM33 gene. This alteration results from a G to A substitution at nucleotide position 1615, causing the glutamic acid (E) at amino acid position 539 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;L
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
N;N;.;N
REVEL
Benign
Sift
Benign
T;T;.;T
Sift4G
Benign
T;T;T;T
Polyphen
D;D;.;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at